Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
https://doi.org/10.17650/1994-4098-2010-0-4-98-102
Abstract
The tolerability and efficiency of peritonectomy in combination with hyperthermic intraperitoneal chemoperfusion were studied in patients with pseudomyxoma peritonei. Data from 10 patients were analyzed. The pattern of complications classified as surgical and chemotherapy- associated ones is presented. The long-term results of treatment are demonstrated.
About the Authors
A. G. Abdullayev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
V. A. Gorbunova
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. D. Ter-Ovanesov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
B. E. Polotsky
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Yu. V. Buidenok
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. I. Davydov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Moran B.J., Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003;12:585–603.
2. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69–76.
3. Weaver C.H. Mucocele of the appendix with pseudomucinous degeneration. Am J Surg 1937;36:523–6.
4. Misdraji J., Yantiss R.K., Graeme-Cook F.M. et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27:1089–103.
5. Carr N.J., Emory T.S., Sobin L.H. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2. Arch Pathol Lab Med 2002;126:837–41.
6. Ronnett B.M., Zahn C.M., Kurman R.J. et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to «pseudomyxoma peritonei». Am J Surg Pathol 1995;19:1390–408.
7. Chejfec G., Rieker W.J., Jablokow V.R. et al. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology 1986;90:202–5.
8. Hawes D., Robinson R., Wira R. Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest Radiol 1991;16:80–2.
9. Kahn M.A., Demopoulos R.I. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study. Int J Gynecol Pathol 1992;11:15–23.
10. Ronnett B.M., Seidman J.D. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003;27:650–7.
11. Miner T.J., Shia J., Jaques D.P. et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005;241:300–8.
12. Baratti D., Kusamura S., Nonaka D. et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008;15:526–34.
13. Butterworth S.A., Panton N.M., Klaassen D.J. et al. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg 2002;183:529–32.
14. Elias D., Lasser P., Reynard B. et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol 2003;27:407–12.
15. Gonzalez-Moreno S., Sugarbaker P.H. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004;91:304–11.
16. Guner Z., Schmidt U., Dahlke M.H. et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005;20:155–60.
17. Loungnarath R., Causeret S., Bossard N. et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonea: a prospective study. Dis Colon Rectum 2005;48:1372–9.
18. Murphy E.M., Sexton R., Moran B.J. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 2006;50:37– 42.
19. Smeenk R.M., Verwaal V.J., Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei – a report of 103 procedures. Eur J Surg Oncol 2006;32:186–90.
20. Sugarbaker P.H., Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–31.
21. Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Michigan: Ludann Company, 1998.
Review
For citations:
Abdullayev A.G., Gorbunova V.A., Ter-Ovanesov M.D., Polotsky B.E., Buidenok Yu.V., Davydov M.I. Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma. Tumors of female reproductive system. 2010;(4):98-102. (In Russ.) https://doi.org/10.17650/1994-4098-2010-0-4-98-102
Views:
543
Email this article 